Opthea Future Growth
Future criteria checks 5/6
Opthea is forecast to grow earnings and revenue by 59.9% and 62.9% per annum respectively while EPS is expected to grow by 59.7% per annum.
Key information
59.9%
Earnings growth rate
59.7%
EPS growth rate
Biotechs earnings growth | 31.8% |
Revenue growth rate | 62.9% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 30 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2026 | 103 | -31 | 72 | 72 | 7 |
6/30/2025 | 11 | -145 | -136 | -128 | 7 |
6/30/2024 | 1 | -180 | -166 | -161 | 7 |
12/31/2023 | 0 | -162 | -121 | -121 | N/A |
9/30/2023 | 0 | -152 | -121 | -121 | N/A |
6/30/2023 | 0 | -143 | -121 | -121 | N/A |
3/31/2023 | 0 | -137 | -116 | -116 | N/A |
12/31/2022 | 0 | -132 | -112 | -112 | N/A |
9/30/2022 | 0 | -113 | -92 | -92 | N/A |
6/30/2022 | 0 | -93 | -71 | -71 | N/A |
3/31/2022 | 0 | -75 | -64 | -64 | N/A |
12/31/2021 | 0 | -57 | -56 | -56 | N/A |
9/30/2021 | 0 | -51 | -51 | -51 | N/A |
6/30/2021 | 0 | -45 | -46 | -46 | N/A |
3/31/2021 | 0 | -39 | -36 | -36 | N/A |
12/31/2020 | 0 | -31 | -27 | -27 | N/A |
9/30/2020 | 0 | -21 | -16 | -16 | N/A |
6/30/2020 | 0 | -11 | -6 | -6 | N/A |
3/31/2020 | 0 | -10 | -7 | -7 | N/A |
12/31/2019 | 0 | -12 | -10 | -10 | N/A |
9/30/2019 | 0 | -13 | -13 | -13 | N/A |
6/30/2019 | 0 | -15 | -17 | -17 | N/A |
3/31/2019 | 0 | -13 | -14 | -14 | N/A |
12/31/2018 | 0 | -12 | -11 | -11 | N/A |
9/30/2018 | 0 | -12 | -13 | -13 | N/A |
6/30/2018 | 0 | -13 | -15 | -15 | N/A |
3/31/2018 | 0 | -12 | -13 | -13 | N/A |
12/31/2017 | 0 | -12 | -12 | -11 | N/A |
9/30/2017 | 0 | -8 | N/A | -8 | N/A |
6/30/2017 | 0 | -5 | N/A | -5 | N/A |
3/31/2017 | 0 | -5 | N/A | -4 | N/A |
12/31/2016 | 0 | -5 | N/A | -3 | N/A |
9/30/2016 | 0 | -5 | N/A | -3 | N/A |
6/30/2016 | 0 | -5 | N/A | -3 | N/A |
3/31/2016 | 0 | -4 | N/A | -2 | N/A |
12/31/2015 | 0 | -3 | N/A | -1 | N/A |
9/30/2015 | 0 | -3 | N/A | -2 | N/A |
6/30/2015 | 0 | -4 | N/A | -4 | N/A |
3/31/2015 | 1 | -4 | N/A | -4 | N/A |
12/31/2014 | 1 | -4 | N/A | -4 | N/A |
9/30/2014 | 1 | -4 | N/A | -4 | N/A |
6/30/2014 | 1 | -4 | N/A | -4 | N/A |
3/31/2014 | 1 | -3 | N/A | -4 | N/A |
12/31/2013 | 1 | -2 | N/A | -4 | N/A |
9/30/2013 | 1 | -3 | N/A | -5 | N/A |
6/30/2013 | 1 | -4 | N/A | -5 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: UKJ is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.7%).
Earnings vs Market: UKJ is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: UKJ is expected to become profitable in the next 3 years.
Revenue vs Market: UKJ's revenue (62.9% per year) is forecast to grow faster than the German market (5.5% per year).
High Growth Revenue: UKJ's revenue (62.9% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if UKJ's Return on Equity is forecast to be high in 3 years time